Expert Interview
Obesity/Diabetes Series-May 2024 (3): A broad discussion on the use of GLP-1 medications for the management of obesity and type 2 diabetes
Ticker(s): LLY, NVOInstitution: Scripps
- Endocrinologist and obesity medicine specialist at the Scripps Clinic Center for Weight Management
- Clinical Professor of Medicine who sees 55 patients weekly with obesity and type 2 diabetes
- Clinical interests include obesity pharmacotherapy, type 2 diabetes, and binge eating disorder
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
